Phase II trial of histone-H1-3 (OncoHist) in patients with refractory acute myeloid leukaemia and non-Hodgkin's lymphoma.

Trial Profile

Phase II trial of histone-H1-3 (OncoHist) in patients with refractory acute myeloid leukaemia and non-Hodgkin's lymphoma.

Recruiting
Phase of Trial: Phase II

Latest Information Update: 21 May 2014

At a glance

  • Drugs Histone H1-3 (Primary) ; Cytarabine; Mitoxantrone
  • Indications Acute myeloid leukaemia; Non-Hodgkin's lymphoma
  • Focus Therapeutic Use
  • Acronyms ARAHIST-90
  • Sponsors SymbioTec
  • Most Recent Events

    • 07 Jul 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top